Search results for " conference" in Articles / App Notes
Article
Vaccine Development Faces Urgency and Challenges
At a Ministerial Conference on Immunization in Africa in February 2016, officials emphasized the need for greater funding of national immunization programs, including expanded regional capacity for va…
Article
Quality by design for biotechnology products—part 1
Rathore, PhD, Mark Schenerman, Tim Schofield, Samantha Sheridan, Paul Smock, Sally Anliker, Lois Atkins, Bernerd McGarvey, Bruce Meiklejohn, Jim Precup, John Towns
ABSTRACT
The International C…
Article
You are invited to attend DiPIA 2024
DiPIA, or Developments in Protein Interaction Analysis, is a global scientific conference hosted by Cytiva. We bring peers together from across the industry to share best practices, research, and new …
Article
Save the date for HTPD 2025
We are pleased to announce the 7th International Conference devoted to High-Throughput Process Development (HTPD) and smart PD, to be held May 26–29 2025 in Uppsala, Sweden.
The program and…
Article
Join DiPIA 2022
More information on topics and agenda can be seen at the conference registration page.
Looking forward to seeing you at DiPIA.
REGISTER TODAY >>
Article
The Need for Advanced Process Modeling for New Therapeutic Biologics
Moore, “Quality by Design—FDA Lessons Learned and Challenges for International Harmonization,” presentation at International Conference on Drug Development (Austin, TX, Feb. 28, 2012).
2. P. Kro…
Article
N-Glycan Analysis of Biotherapeutic Proteins
Jones, “N-Glycan Analysis using InstantDye Workflows for the Screening & Characterization of Biotherapuetics,” presentation at the WCBP Conference (Washington, DC, 2017).
32. R. Upton et al., …
Article
Lessons Learned Accelerate Vaccine Development
Collaboration and single-use technologies aided the rapid scale-up of Ebola vaccine manufacturing.
By Cynthia A. Challener
Vaccine development is a complicated process that can take many yea…
Article
Tackling Analytical Method Development for ADCs
“Testing requirements will still be identity, purity, impurities, activity, concentration, and stability as outlined in the International Conference on Harmonization’s ICH Q5C (1) and ICH Q6B (2) biol…
Article
Defining Critical Quality Attributes for Monoclonal Antibody Therapeutic Products
Mhatre, “LC-ESI/MS and MALDI-MS for Monitoring of Glycoform-Related Clearance of a Complex Glycoprotein in Cynomolgus Monkeys,” presentation at the 58th ASMS Conference on Mass Spectrometry (Salt Lake…